Welcome to the BioLogicTube jeo@biologicmedia.dk https://biologictube.dk/app/facebook en-us Visualplatform http://blogs.law.harvard.edu/tech/rss Welcome to the BioLogicTube episodic no https://biologictube.dk/app/facebook/files/rv0.0/sitelogo.gif https://biologictube.dk/app/facebook http://biologictube.dk/photo/53580443/prof-peter-rossing-on-diabetes <p>Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long)</p><p><a href="http://biologictube.dk/photo/53580443/prof-peter-rossing-on-diabetes"><img src="http://biologictube.dk/49543318/53580443/a34f811ef3ad7f14e2072b914382ec3a/standard/download-2-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/53580443 Wed, 03 Jul 2019 12:53:40 GMT Prof. Peter Rossing on diabetes complications Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long) Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter... Welcome to the BioLogicTube 05:34 <p>Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long)</p><p><a href="http://biologictube.dk/photo/53580443/prof-peter-rossing-on-diabetes"><img src="http://biologictube.dk/49543318/53580443/a34f811ef3ad7f14e2072b914382ec3a/standard/download-2-thumbnail.jpg" width="600" height="338"/></a></p> cardiovascular complications early intervention early prediction End-stage renal disease ESRD Jesper Eugen-Olsen Jørgen Jeppesen late stage complications Persson F risk prediction Simone Theilade soluble urokinase plasminogen activator receptor suPAR Tine W. Hansen Tofte N Type 1 diabetes Viktor Curovic Winther SA http://biologictube.dk/photo/10033014/overview-of-the-5th-international-supar <p>The 5th suPAR symposium was hosted by Prof. Markus Schultz and held at the Amsterdam Medical Center in May 2014. New and recently published data were presented and gave insights into the clinical use of suPAR. This years focus was on the use of suPAR as a risk triage marker in the Acute Medical Department. Data from the routine use as well research data complemented into a conclusion that suPAR helps changing the clinical decision. Should the patient be admitted? Sent home? Rushed to the ICU? This and more was discussed by almost 100 clinicians and researchers over the 2-day seminar.</p><p><a href="http://biologictube.dk/photo/10033014/overview-of-the-5th-international-supar"><img src="http://biologictube.dk/9826383/10033014/acaf7b023048d8ce68e8cd246c8ce21f/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/10033014 Fri, 25 Jul 2014 14:38:49 GMT Overview of the 5'th International suPAR symposium The 5th suPAR symposium was hosted by Prof. Markus Schultz and held at the Amsterdam Medical Center in May 2014. New and recently published data were presented and gave insights into the clinical use of suPAR. This years focus was on the use of suPAR as a risk triage marker in the Acute Medical Department. Data from the routine use as well research data complemented into a conclusion that suPAR helps changing the clinical decision. Should the patient be admitted? Sent home? Rushed to the ICU? This and more was discussed by almost 100 clinicians and researchers over the 2-day seminar. The 5th suPAR symposium was hosted by Prof. Markus Schultz and held at the Amsterdam Medical Center in May 2014. New and recently published data were presented and gave insights into the clinical use of suPAR. This years focus was on the use of... Welcome to the BioLogicTube 04:55 <p>The 5th suPAR symposium was hosted by Prof. Markus Schultz and held at the Amsterdam Medical Center in May 2014. New and recently published data were presented and gave insights into the clinical use of suPAR. This years focus was on the use of suPAR as a risk triage marker in the Acute Medical Department. Data from the routine use as well research data complemented into a conclusion that suPAR helps changing the clinical decision. Should the patient be admitted? Sent home? Rushed to the ICU? This and more was discussed by almost 100 clinicians and researchers over the 2-day seminar.</p><p><a href="http://biologictube.dk/photo/10033014/overview-of-the-5th-international-supar"><img src="http://biologictube.dk/9826383/10033014/acaf7b023048d8ce68e8cd246c8ce21f/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> alexander koch artigas beat muller crp denmark diagnosis diagnostic elisa finland france frank tacke gremany helle fisker jakob knudsen jesper eugen-olsen jurki thenunen kenya margarethe persson ove andersen pct poland pro-adm procalcitonine prognosis prognostic quick triage soluble urokinase plasminogen acivator receptor suparnostic sweden terese djärv tine k andersen torben mogensen